These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1389469)

  • 1. Vascular damage and tumour response.
    Murray JC
    Eur J Cancer; 1992; 28A(10):1593-4. PubMed ID: 1389469
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular disrupting agents.
    Lippert JW
    Bioorg Med Chem; 2007 Jan; 15(2):605-15. PubMed ID: 17070061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.
    Phillips P
    JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular markers of lymphatic and blood vessels, tumorigenesis and targets for blocking metastatic spreading].
    Konenkov VI; Borodin IuI; Bgatova NP
    Vopr Onkol; 2011; 57(3):295-301. PubMed ID: 21882598
    [No Abstract]   [Full Text] [Related]  

  • 5. Taking down tumors: vascular disrupting agents entering clinical trials.
    O'Hanlon LH
    J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular disrupting agents in clinical development.
    Hinnen P; Eskens FA
    Br J Cancer; 2007 Apr; 96(8):1159-65. PubMed ID: 17375046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular attack as a therapeutic strategy for cancer.
    Denekamp J
    Cancer Metastasis Rev; 1990 Nov; 9(3):267-82. PubMed ID: 2292139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular toxicity of chemotherapeutic agents.
    López-Miranda V; Herradón E; González C; Martín MI
    Curr Vasc Pharmacol; 2010 Sep; 8(5):692-700. PubMed ID: 19758112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action.
    Le Serve AW; Hellmann K
    Br Med J; 1972 Mar; 1(5800):597-601. PubMed ID: 4111169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editoral: ICRF 159.
    Lancet; 1974 Mar; 1(7853):344-5. PubMed ID: 4131178
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions.
    Lin Z; Zhang Q; Luo W
    Eur J Pharmacol; 2016 Dec; 793():76-81. PubMed ID: 27840192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial injury caused by antineoplastic agents.
    Lazo JS
    Biochem Pharmacol; 1986 Jun; 35(12):1919-23. PubMed ID: 2424454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-radiation interactions in tumor blood vessels.
    Hallahan DE; Chen AY; Teng M; Cmelak AJ
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):71-7. PubMed ID: 10550829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What "helps" tumors evade vascular targeting treatment?
    Si ZC; Liu J
    Chin Med J (Engl); 2008 May; 121(9):844-9. PubMed ID: 18701052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible nonimmunologic biological response to neoplasia: the tumor fibrovascular stroma.
    Machado EA
    J Biol Response Mod; 1985 Feb; 4(1):3-7. PubMed ID: 2580062
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.
    Zwi LJ; Baguley BC; Gavin JB; Wilson WR
    Br J Cancer; 1990 Aug; 62(2):231-7. PubMed ID: 2386739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
    Folkman J
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular effects of photodynamic therapy.
    Krammer B
    Anticancer Res; 2001; 21(6B):4271-7. PubMed ID: 11908681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-factor fusion proteins induce occlusion of tumor vessels.
    Schwöppe C; Kessler T; Persigehl T; Liersch R; Hintelmann H; Dreischalück J; Ring J; Bremer C; Heindel W; Mesters RM; Berdel WE
    Thromb Res; 2010 Apr; 125 Suppl 2():S143-50. PubMed ID: 20433995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery.
    Matsumoto Y; Nichols JW; Toh K; Nomoto T; Cabral H; Miura Y; Christie RJ; Yamada N; Ogura T; Kano MR; Matsumura Y; Nishiyama N; Yamasoba T; Bae YH; Kataoka K
    Nat Nanotechnol; 2016 Jun; 11(6):533-538. PubMed ID: 26878143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.